Splinex Technology Inc. (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   December 8, 2005

Splinex Technology Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 333-116817 200715816
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
550 W. Cypress Creek Road, Suite 410, Fort Lauderdale, Florida   33309
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   954 660-6565

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On December 8, 2005, Kevin Fitzgerald resigned as Chairman and director of the Board of Directors of the Company, and as a member of the Compensation Committee and Audit Committee of the Board.

On December 11, 2005, the Board of Directors of the Company elected Dr. Peter Novak, a director of the Company, as Chairman. The Board also appointed Alexander Yarmolinsky and Edward Dubrovsky as members of the Compensation Committee. Dr. Novak also resigned as a member of the Compensation Committee of the Board at this time.





Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Splinex Technology Inc.
          
December 13, 2005   By:   /s/ Gerard Herlihy
       
        Name: Gerard Herlihy
        Title: President